388 related articles for article (PubMed ID: 36833509)
1. Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review.
Kunachowicz D; Ściskalska M; Kepinska M
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833509
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Sci; 2013 Dec; 22(12):1799-807. PubMed ID: 24123308
[TBL] [Abstract][Full Text] [Related]
3. Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus.
Zhou M; Liu XH; Liu QQ; Chen M; Bai H; Guan LB; Fan P
J Diabetes Res; 2020; 2020():3483427. PubMed ID: 32090118
[TBL] [Abstract][Full Text] [Related]
4. The paraoxonase 1, 2 and 3 in humans.
Rajkovic MG; Rumora L; Barisic K
Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
[TBL] [Abstract][Full Text] [Related]
5. A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease.
Petrič B; Kunej T; Bavec A
OMICS; 2021 Jan; 25(1):38-51. PubMed ID: 33306925
[TBL] [Abstract][Full Text] [Related]
6. The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase.
Otocka-Kmiecik A; Orłowska-Majdak M
Postepy Hig Med Dosw (Online); 2009 Dec; 63():668-77. PubMed ID: 20097953
[TBL] [Abstract][Full Text] [Related]
7. Modulation of paraoxonase (PON1) activity.
Costa LG; Vitalone A; Cole TB; Furlong CE
Biochem Pharmacol; 2005 Feb; 69(4):541-50. PubMed ID: 15670573
[TBL] [Abstract][Full Text] [Related]
8. Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome.
Zhang Y; Liu H; He J; Xu K; Bai H; Wang Y; Zhang F; Zhang J; Cheng L; Fan P
Eur J Endocrinol; 2015 Apr; 172(4):391-402. PubMed ID: 25575948
[TBL] [Abstract][Full Text] [Related]
9. The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation.
Mahrooz A; Mackness M; Bagheri A; Ghaffari-Cherati M; Masoumi P
Clin Biochem; 2019 Nov; 73():1-10. PubMed ID: 31351988
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase 1 activities and genetic variation in childhood obesity.
Rupérez AI; López-Guarnido O; Gil F; Olza J; Gil-Campos M; Leis R; Tojo R; Cañete R; Gil A; Aguilera CM
Br J Nutr; 2013 Nov; 110(9):1639-47. PubMed ID: 23789921
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
12. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.
Deakin SP; James RW
Clin Sci (Lond); 2004 Nov; 107(5):435-47. PubMed ID: 15265000
[TBL] [Abstract][Full Text] [Related]
13. Changes in lipid profile parameters and PON1 status associated with L55M PON1 polymorphism, overweight and exposure to tobacco smoke.
Bizoń A; Ołdakowska M; Milnerowicz H
Inhal Toxicol; 2018; 30(11-12):463-471. PubMed ID: 30618305
[TBL] [Abstract][Full Text] [Related]
14. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.
Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T
Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.
Costa LG; Giordano G; Furlong CE
Biochem Pharmacol; 2011 Feb; 81(3):337-44. PubMed ID: 21093416
[TBL] [Abstract][Full Text] [Related]
16. The growing importance of PON1 in cardiovascular health: a review.
Macharia M; Hassan MS; Blackhurst D; Erasmus RT; Matsha TE
J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):443-53. PubMed ID: 22673025
[TBL] [Abstract][Full Text] [Related]
17. Towards Understanding the Catalytic Mechanism of Human Paraoxonase 1: Experimental and In Silico Mutagenesis Studies.
Tripathy RK; Aggarwal G; Bajaj P; Kathuria D; Bharatam PV; Pande AH
Appl Biochem Biotechnol; 2017 Aug; 182(4):1642-1662. PubMed ID: 28161867
[TBL] [Abstract][Full Text] [Related]
18. Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies.
Bae SS; Shahbazian A; Wang J; Golub I; Oganesian B; Dowd T; Vayngortin B; Wang R; Elashoff D; Reddy ST; Charles-Schoeman C
Rheumatology (Oxford); 2022 May; 61(6):2512-2523. PubMed ID: 34698804
[TBL] [Abstract][Full Text] [Related]
19. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.
Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J
Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660
[TBL] [Abstract][Full Text] [Related]
20. Effects of intronic and exonic polymorphisms of paraoxonase 1 (PON1) gene on serum PON1 activity in a Korean population.
Eom SY; Kim YS; Lee CJ; Lee CH; Kim YD; Kim H
J Korean Med Sci; 2011 Jun; 26(6):720-5. PubMed ID: 21655055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
